rs752400396
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000426.4(LAMA2):c.5079T>A(p.Asn1693Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,482 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N1693S) has been classified as Uncertain significance.
Frequency
Consequence
NM_000426.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital merosin-deficient muscular dystrophy 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- LAMA2-related muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal recessive 23Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000426.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | NM_000426.4 | MANE Select | c.5079T>A | p.Asn1693Lys | missense | Exon 36 of 65 | NP_000417.3 | ||
| LAMA2 | NM_001079823.2 | c.5079T>A | p.Asn1693Lys | missense | Exon 36 of 64 | NP_001073291.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | ENST00000421865.3 | TSL:5 MANE Select | c.5079T>A | p.Asn1693Lys | missense | Exon 36 of 65 | ENSP00000400365.2 | ||
| LAMA2 | ENST00000618192.5 | TSL:5 | c.5343T>A | p.Asn1781Lys | missense | Exon 37 of 66 | ENSP00000480802.2 | ||
| LAMA2 | ENST00000617695.5 | TSL:5 | c.5079T>A | p.Asn1693Lys | missense | Exon 36 of 64 | ENSP00000481744.2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152090Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 249884 AF XY: 0.00
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461392Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 726978 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74298 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Distal myopathy Uncertain:1
Inborn genetic diseases Uncertain:1
The c.5079T>A (p.N1693K) alteration is located in exon 36 (coding exon 36) of the LAMA2 gene. This alteration results from a T to A substitution at nucleotide position 5079, causing the asparagine (N) at amino acid position 1693 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at